The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system

Journal of Neuroimmunology

Volumn 110, Issue 1-2, 2000, Pages 177-185

  Siebert, Heike ^a   Sachse, Anika ^a   Kuziel, William A ^b   Maeda, Nobuyo ^c   Brück, Wolfgang ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine receptors CCR2 and CCR5; Chemokines; Macrophages; Myelin phagocytosis; Sciatic nerve; Wallerian degeneration

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; NERVE DEGENERATION; NERVE FIBER TRANSECTION; NERVE INJURY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; TH1 CELL;

ANIMAL; ANTIGENS, DIFFERENTIATION; CELL MOVEMENT; GENE EXPRESSION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MYELIN PROTEINS; MYELIN SHEATH; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; SCIATIC NERVE; SUPPORT, NON-U.S. GOV'T; WALLERIAN DEGENERATION;

EID: 0034597059     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00343-X     Document Type: Article

References (60)

1. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., et al. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:1994;97-179.
3. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 15:1997;675-705.
4. Berman J.W., Guida M.P., Warren J., Amat J., Brosnan C.F. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:1996;3017-3023.
5. Beuche W., Friede R.L. The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13:1984;767-796.
6. Beuche W., Friede R.L. Millipore diffusion chambers allow dissociation of myelin phagocytosis by non-resident cells and of allogenic nerve graft rejection. J. Neurol. Sci. 69:1985;231-246.
7. Bolin L.M., Verity A.N., Silver J.E., Shooter E.M., Abrams J.S. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64:1995;850-858.
8. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129-134.
9. Brown H.C., Castano A., Feam S., Townsend M., Edwards G., Streuli C., et al. Adhesion molecules involved in macrophage responses to Wallerian degeneration in the murine peripheral nervous system. Eur. J. Neurosci. 9:1997;2057-2063.
10. Brück W. The role of macrophages in Wallerian degeneration. Brain Pathol. 7:1997;741-752.
11. Brück W., Brück Y., Maruschak B., Friede R.L. Mechanisms of macrophage recruitment in Wallerian degeneration. Acta Neuropathol. 89:1995;363-367.
12. Brück W., Friede R.L. The role of complement in myelin phagocytosis during PNS Wallerian degeneration. J. Neurol. Sci. 103:1991;182-187.
13. Brück W., Huitinga I., Dijkstra C.D. Liposome-mediated monocyte depletion during Wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J. Neurosci. Res. 46:1996;477-484.
14. Carroll S.L., Frohnert P.W. Expression of JE (monocyte chemoattractant protein-1) is induced by sciatic axotomy in wild type rodents but not in C57BL/Wld mice. J. Neuropathol. Exp. Neurol. 57:1998;915-930.
15. Christensen P.J., Rolfe M.W., Standiford T.J., Burdick M.D., Toews G.B., Strieter R.M., et al. Characterization of the production of monocyte chemoattractant protein-1 and IL-8 in an allogeneic immune response. J. Immunol. 151:1993;1205-1213.
16. Conklyn M.J., Neote K., Showell H.J. Chemokine-dependent upregulation of CD11b on specific leukocyte subpopulations in human whole blood: effect of anticoagulant on RANTES and MIP-1β stimulation. Cytokine. 8:1996;762-766.
17. Dailey A.T., Avellino A.M., Benthem L., Silver J., Kliot M. Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration. J. Neurosci. 18:1998;6713-6722.
18. Dawson T.C., Beck M.A., Kuziel W.A., Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to Influenza A virus. Am. J. Pathol. 156:2000;1951-1959.
19. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 143:1999;205-211.
20. Deng H.K., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
21. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
22. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
23. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
24. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol. 155:1995;5769-5776.
25. Fujioka T., Kolson D.L., Rostami A.M. Chemokines and peripheral nerve demyelination. J. Neurovirol. 5:1999;27-31.
26. Gale L.M., McColl S.R. Chemokines: extracellular messengers for all occasions? Bioessays. 21:1999;17-28.
27. Ghirnikar R.S., Lee Y.L., He T.R., Eng L.F. Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 46:1996;727-733.
28. Gillen C., Jander S., Stoll G. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and Wallerian degeneration. J. Neurosci. Res. 51:1998;489-496.
29. Glabinski A.R., Balasingam V., Tani M., Kunkel S.L., Strieter R.M., Wee Yong V., et al. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156:1996;4363-4368.
30. Glabinski A.R., Ransohoff R.M. Chemokines and chemokine receptors in CNS pathology. J. Neurovirol. 5:1999;3-12.
31. Griffin J.W., George R., Lobato C., Tyor W.R., Yan L.C., Glass J.D., et al. Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination. J. Neuroimmunol. 40:1992;153-166.
32. Hesselgesser J., Horuk R. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:1999;13-26.
33. Huffnagle G.B., McNeil L.K., McDonald R.A., Murphy J.W., Toews G.B., Maeda N., et al. Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J. Immunol. 163:1999;4642-4646.
34. Huitinga I., van Rooijen N., De Groot C.J.A., Uitdehaag B.M.J., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1990;1025-1033.
35. Ito Y., Yamamoto M., Li M., Doyu M., Tanaka F., Mutch T., et al. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR α, LIFR β, IL-6R α and gp130) in injured peripheral nerves. Brain Res. 793:1998;321-327.
36. Jiang Y., Salafranca M.N., Adhikari S., Xia Y., Feng L., Sonntag M.K., et al. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J. Neuroimmunol. 86:1998;1-12.
37. Jung S., Huitinga I., Schmidt B., Zielasek J., Dijkstra C.D., Toyka K.V., et al. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis. J. Neurol. Sci. 119:1993;195-202.
38. Kunkel S.L., Lukacs N., Kasama T., Strieter R.M. The role of chemokines in inflammatory joint disease. J. Leukocyte Biol. 59:1996;6-12.
39. Kunkel S.L., Strieter R.M., Lindley I.J.D., Westwick J. Chemokines: new ligands, receptors and activities. Immunol. Today. 16:1995;559-561.
40. Kuziel W.A., Morgan S.J., Dawson T.C., Griffin S., Smithies O., Ley K., et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA. 94:1997;12053-12058.
41. Loetscher P., Uguccioni M., Bordoli L., Baggiolini M., Moser B., Chizzolini C., et al. CCR5 is characteristic of Th 1 lymphocytes. Nature. 391:1998;344-345.
42. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:1998;601-608.
43. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1:1989;27-33.
44. Moalem G., Monsonego A., Shani Y., Cohen I.R., Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13:1999;1207-1217.
45. Negus R.P.M. The chemokines: cytokines that direct leukocyte migration. J. R. Soc. Med. 89:1996;312-314.
46. Perry V.H., Brown M.C., Lunn E.R., Tree P., Gordon S. Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur. J. Neurosci. 2:1990;802-808.
47. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:1998;746-754.
48. Ransohoff R.M. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J. Leukocyte Biol. 62:1997;645-652.
49. Raport C.J., Schweickart V.L., Chantry D., Eddy R.L. Jr., Shows T.B., Godiska R., et al. New members of the chemokine receptor gene family. J. Leukocyte Biol. 59:1996;18-23.
50. Rollins B.J. Chemokines. Blood. 90:1997;909-928.
51. Ruffing N., Sullivan N., Sharmeen L., Sodroski J., Wu L. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell. Immunol. 189:1998;160-168.
52. Rutkowski J.L., Tuite G.F., Lincoln P.M., Boyer P.J., Tennekoon G.I., Kunkel S.L., et al. Signals for proinflammatory cytokine secretion by human Schwann cells. J. Neuroimmunol. 101:1999;47-60.
53. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., Luster A.D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185:1997;99-109.
54. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815.
55. Stoll G., Griffin J.W., Li C.Y., Trapp B.D. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18:1989;671-683.
56. Toews A.D., Barrett C., Morell P. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J. Neurosci. Res. 53:1998;260-267.
57. Tran E.H., Kuziel W.A., Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptor. Eur. J. Immunol. 30:2000;1410-1415.
58. Traynor T.R., Kuziel W.A., Toews G.B., Huffnagle G.B. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2000;2021-2027.
59. Vougioukas V.I., Roeske S., Michel U., Brück W. Wallerian degeneration in ICAM-1-deficient mice. Am. J. Pathol. 152:1998;241-249.
60. Weber K.S., Klickstein L.B., Weber C. Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains. Mol. Biol. Cell. 10:1999;861-873.